Vivian Lee, president and CEO of Linical Taiwan, documents the affiliate’s main milestones since its establishment in 2013, its strategic positioning among the Linical Group as a regional hub, as well as the crucial role Linical Taiwan aims to play in further propelling the impressive growth of Taiwan’s R&D-driven biopharmaceutical industry.
The Taiwanese affiliate of the Japan-headquartered Linical Group, a rapidly growing international CRO, was established in 2013. What was the mission you were entrusted with when taking over the helm of this affiliate in 2014?
"Japan, Taiwan and Korea stand as the Group’s core markets in the region, and the Korean and Taiwanese affiliates are directly reporting to the group’s headquarters in Japan."
